TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間:2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
81
Lee CC, Chou YJ, Lin JN, Chu FY, Tang HJ, Lai CH, Lin HH, Hung CC, Ko WC. Clinical predictors of the leading pathogens in human immunodeficiency virus-infected adults with community-onset bacteremia in the emergency department: The importance of transmission routes. J Microbiol Immunol Infect. 2018 Jun;51(3):392-400. doi: 10.1016/j.jmii.2016.08.001. Epub 2016 Dec 18. PMID: 28082067.
82
Lee YC, Hung CC, Cheng A, Liu WC, Wu PY, Yang SP, Zhang JY, Luo YZ, Chang HY, Sun HY, Chang SC. Willingness of human immunodeficiency virus-positive patients to donate their organs for transplantation in Taiwan: a cross-sectional questionnaire survey. Transpl Infect Dis. 2016 Dec;18(6):856-861. doi: 10.1111/tid.12614. Epub 2016 Nov 11. PMID: 27663143.
83
Huang YS, Chang SY, Sheng WH, Sun HY, Lee KY, Chuang YC, Su YC, Liu WC, Hung CC, Chang SC. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016 Dec 29;11(12):e0169228. doi: 10.1371/journal.pone.0169228. PMID: 28033344; PMCID: PMC5199102.
84
Chou YJ, Lin HW, Yang CJ, Chen MY, Sheng WH, Liu WC, Chang SY, Hung CC, Hsueh PR, Chang SC. Risk of recurrent nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected patients with short-term secondary prophylaxis in the era of combination antiretroviral therapy. J Microbiol Immunol Infect. 2016 Oct;49(5):760-767. doi: 10.1016/j.jmii.2015.07.005. Epub 2015 Jul 31. PMID: 26316009.
85
Cheng A, Chang SY, Tsai MS, Su YC, Liu WC, Sun HY, Hung CC. Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy. J Int AIDS Soc. 2016 Jan 29;19(1):20631. doi: 10.7448/IAS.19.1.20631. PMID: 26829360; PMCID: PMC4733944.